Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

May 14, 2015

Primary Completion Date

September 1, 2017

Study Completion Date

April 30, 2019

Conditions
Prostate Cancer
Interventions
DEVICE

AR-v7 assays

Trial Locations (5)

10065

Memorial Sloan Kettering Cancer Center, New York

Weill Medical College of Cornell University, New York

21287

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore

27710

Duke University, Durham

60637

University of Chicago, Chicago

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

Epic Sciences

INDUSTRY

collaborator

Prostate Cancer Foundation

OTHER

lead

Duke University

OTHER